TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Japan approves dexamethasone as coronavirus treatment

  • News Desk

    Reuters

Tokyo, Japan   /   Wed, July 22, 2020   /   07:35 am
Japan approves dexamethasone as coronavirus treatment A picture taken on June 16, 2020 in Paris shows tablets of Dectancyl, a drug manufactured by Sanofi containing dexamethasone.Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalized patients. (AFP/Bertrand Guay )

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalized patients.

The ministry included dexamethasone as an option for treatment along with antiviral drug remdesivir in a recent revision to its handbook. The revision was widely reported by Japanese media on Wednesday.

In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic.

Japan's Nichi-Iko Pharmaceutical Co is among those that produce the drug.